Cite
HARVARD Citation
Zhang, M. et al. (n.d.). 568 XTX201, a protein-engineered IL-2, exhibits tumor-selective activity in mice without peripheral toxicities in non-human primates. Journal for immunotherapy of cancer. p. A602. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, M. et al. (n.d.). 568 XTX201, a protein-engineered IL-2, exhibits tumor-selective activity in mice without peripheral toxicities in non-human primates. Journal for immunotherapy of cancer. p. A602. [Online].